| BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program | 06/27 07:40 | globenewswire.com |
| BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results | 06/17 07:05 | globenewswire.com |
| Why Is BioRestorative Therapeutics (BRTX) Stock Up 42% Today? | 06/13 11:10 | investorplace.com |
| BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program | 06/13 07:00 | globenewswire.com |
| Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Tops Revenue Estimates | 06/11 18:50 | zacks.com |
| BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference | 06/04 08:50 | globenewswire.com |
| BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice | 05/24 19:45 | globenewswire.com |
| BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market | 05/15 09:00 | accesswire.com |
| BioRestorative Therapies, Inc. (BRTX) Q1 2024 Earnings Call Transcript | 05/14 19:08 | seekingalpha.com |
| BioRestorative Therapies Provides First Quarter 2024 Business Update | 05/14 16:10 | globenewswire.com |